Nanjing Wells Medical Technology Co., Ltd. Announces Amendment to Shareholding Reduction Plan by Shareholder and Its Concert Parties

This article is reproduced from: Securities Times

The board of directors and all directors of this company guarantee that there are no false records, misleading statements, or significant omissions in the content of this announcement, and they assume legal responsibility for the authenticity, accuracy, and completeness of its content.

Important Content Tips:

● On March 24, 2022, Nanjing Vishee Medical Technology Co., Ltd. (hereinafter referred to as the "Company") received a "Notice of Change in Share Reduction Plan" from the Company's shareholder Shenzhen Yanghe Biomedical Industry Investment Co., Ltd. (hereinafter referred to as "Yanghe Investment") and its concerted parties Lian Qingming, Su Cailong, Li Xiaoming, Shi Zhuangping, Tan Fei, Yang Chongxiang, Zhou Dongyao, and Zheng Guihua. The proposed change involves the reduction price, which will be changed from "at market price" to "for reductions conducted through centralized bidding, the price shall not be less than RMB 100 per share (inclusive); for reductions through block trading, at market price." The planned number of shares to be reduced remains unchanged.

Nanjing Vishee Medical Technology Co., Ltd. Announces Shareholders and Concert Parties' Plan to Reduce Shares (Announcement No.: 2022-003)

On March 24, 2022, the company received a "Notice of Change in Share Reduction Plan" from Yanghe Investment and its acting-in-concert parties. Based on confidence in the company’s future continuous and stable development and judgment of the company’s value, combined with their own capital arrangements, and after comprehensive consideration, Yanghe Investment and its acting-in-concert parties proposed to change the share reduction price from "at market price" to "for reductions conducted through centralized bidding, the price shall be no less than RMB 100 per share (inclusive); for reductions conducted through block trading, at market price." The planned number of shares to be reduced remains unchanged.

1. Main Contents of This Change and Reduction Plan

■

2. Other Information

1. The change in this reduction plan is based on the confidence of the company's shareholders, Yanghe Investment and its concert parties Lian Qingming, Su Cailong, Li Xiaoming, Shi Zhuangping, Tan Fei, Yang Chongxiang, Zhou Dongyao, and Zheng Guihua, in the company's future continuous and stable development and their judgment of the company's value. Combined with their own capital arrangements, they have independently decided. This will not have a significant impact on corporate governance, equity structure, or future continuous operations, nor will it lead to changes in the controlling shareholder or actual controller.

2. As of the date of this announcement, the current share reduction plan has not been implemented. During the implementation period of the reduction plan, the shareholders will decide whether and how to implement this share reduction plan based on market conditions, the company's stock price, and other factors. There is uncertainty regarding the timing, price, and quantity of the reduction.

3. The Company will continue to monitor the progress of the shareholders' share reduction plan and fulfill its information disclosure obligations in a timely manner in accordance with relevant laws and regulations.

Hereby announced.

Board of Directors of Nanjing Vishee Medical Technology Co., Ltd.

March 25, 2022